Share on StockTwits

Abcam Plc (LON:ABC)‘s stock had its “hold” rating reiterated by equities researchers at FinnCap in a research report issued on Tuesday. They currently have a GBX 390 ($6.66) price objective on the stock. FinnCap’s target price suggests a potential upside of 2.63% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at N+1 Singer reiterated a “sell” rating on shares of Abcam Plc in a research note on Wednesday, July 16th. They now have a GBX 346 ($5.91) price target on the stock. Separately, analysts at Numis Securities Ltd cut their price target on shares of Abcam Plc from GBX 510 ($8.71) to GBX 490 ($8.37) in a research note on Monday, July 14th. They now have an “add” rating on the stock. Finally, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Abcam Plc in a research note on Tuesday, July 1st. They now have a GBX 510 ($8.71) price target on the stock. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. Abcam Plc has a consensus rating of “Hold” and a consensus price target of GBX 412.17 ($7.04).

Shares of Abcam Plc (LON:ABC) traded up 5.78% during mid-day trading on Tuesday, hitting GBX 380.00. The stock had a trading volume of 1,981,238 shares. Abcam Plc has a 52 week low of GBX 270.88 and a 52 week high of GBX 533.50. The stock’s 50-day moving average is GBX 383.6 and its 200-day moving average is GBX 420.5.

Abcam plc is a producer and distributor of research-grade antibodies and associated protein research tools.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.